ArticleFrontiers in immunology2026

Glycolysis-mediated H3K18la modifications drive aggressive bladder cancer through metabolic and epigenetic reprogramming.

Zhan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.